MyFinsight
Home
Blog
About
Strata Critical Medical, Inc. (SRTAW)
Strata Critical Medical, Inc. (SRTAW)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$27,755K
Free Cash flow
-$1,294K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of held...
Stock-based compensation
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Purchase of property and equipme...
Change in fair value of other as...
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
Net income / (loss)
2,154
-8,833
50,180
Change in gain on sale of business
-344
-3,439
60,435
Depreciation and amortization
3,060
3,008
5,177
Stock-based compensation
5,035
6,586
11,246
Change in fair value of warrant liabilities
-1,459
-1,416
-2,862
Change in fair value of other assets and liabilities
-3,444
1,037
-
Excess of lease liability over operating right-of-use assets
-
0
0
Transaction costs paid related to sale of business
-
1,417
5,964
Gain on lease modification
-
0
-
Acquisition consideration allocated to seller transaction expenses
-
0
44,339
Impairment of intangible assets
-
0
0
Impairment of property and equipment
-
1,673
-
Realized loss from sale of short-term investments
-
0
-5,195
Realized foreign exchange gain
-
0
798
Accretion of interest income on held-to-maturity securities
265
482
1,732
Deferred tax expense
-77
-126
558
Other Operating Activities Cash Flow Statement
27
83
388
Prepaid expenses and other current assets
-383
2,462
-776
Accounts receivable
-149
3,483
8,551
Other non-current assets
-78
0
-666
Operating right-of-use assets/lease liabilities
-73
-2
90
Accounts payable and accrued expenses
-2,158
-6,017
8,395
Deferred revenue
-3
1,684
-
Other current liabilities
-
-
1,583
Increase Decrease In Other Operating Capital Net
12
-
-
Net cash provided by/ (used in) operating activities (includes discontinued operations see note 4)
3,885
-8,307
-40,607
Acquisitions, net of cash acquired
-
1,361
65,174
Cash transfer related to sale of business
290
1,569
1,241
Capitalized software development costs
302
157
1,258
Purchase of property and equipment, net of proceeds from disposal
5,179
1,848
7,747
Purchase of held-to-maturity investments
0
0
146,258
Proceeds from maturities of held-to-maturity investments
30,500
23,200
203,000
Proceeds from sale of short-term investments
-
0
70,163
Net cash provided by investing activities (includes discontinued operations see note 4)
24,729
18,265
51,485
Proceeds from the exercise of common stock options
52
54
139
Taxes paid related to net share settlement of equity awards
582
1,796
7,309
Repurchase and retirement of common stock
-
0
0
Payments for debt issuance costs
329
-
-
Net cash used in financing activities (includes discontinued operations see note 4)
-859
-1,742
-7,170
Effect of foreign exchange rate changes on cash balances
0
0
-339
Net increase in cash and cash equivalents and restricted cash
27,755
8,216
3,369
Cash and cash equivalents and restricted cash - beginning
31,232
23,016
19,647
Cash and cash equivalents and restricted cash - ending
58,987
31,232
23,016
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of...
$30,500K
Stock-based compensation
$5,035K
Depreciation and
amortization
$3,060K
Net income / (loss)
$2,154K
Prepaid expenses and
other current assets
-$383K
Change in gain on sale of
business
-$344K
Accounts receivable
-$149K
Other non-current
assets
-$78K
Operating right-of-use
assets/lease liabilities
-$73K
Other Operating
Activities Cash Flow...
$27K
Net cash provided by
investing activities...
$24,729K
Net cash provided
by/ (used in)...
$3,885K
Canceled cashflow
$5,771K
Canceled cashflow
$7,418K
Net increase in cash
and cash...
$27,755K
Canceled cashflow
$859K
Purchase of property and
equipment, net of proceeds...
$5,179K
Capitalized software
development costs
$302K
Cash transfer
related to sale of...
$290K
Change in fair value of
other assets and...
-$3,444K
Accounts payable and
accrued expenses
-$2,158K
Change in fair value of
warrant liabilities
-$1,459K
Accretion of interest
income on...
$265K
Deferred tax expense
-$77K
Increase Decrease In
Other Operating...
$12K
Deferred revenue
-$3K
Proceeds from the
exercise of common stock...
$52K
Net cash used in
financing activities...
-$859K
Canceled cashflow
$52K
Taxes paid related to
net share...
$582K
Payments for debt
issuance costs
$329K
Buy us a coffee